| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/21/2006 | US20060211147 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211146 Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211145 Diagnostic for insulin resistance |
| 09/21/2006 | US20060211144 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211141 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211140 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211139 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211138 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211118 Induced by fermentable glucose or non-fermentable ethanol |
| 09/21/2006 | US20060211115 Methods of generating chimeric adenoviruses and uses for such chimeric aden oviruses |
| 09/21/2006 | US20060211114 Modulation of hedgehog-mediated signaling pathway |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211093 Membrane scaffold proteins and embedded membrane proteins |
| 09/21/2006 | US20060211092 Membrane scaffold proteins and tethered membrane proteins |
| 09/21/2006 | US20060211091 MAGE-A3 peptides presented by HLA class II molecules |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211089 Expression of defensins in filamentous fungi |
| 09/21/2006 | US20060211087 Compositions and methods for producing recombinant proteins |
| 09/21/2006 | US20060211086 Process for manufacture of nematode-extracted anticoagulant protein (NAP) |
| 09/21/2006 | US20060211085 disruption of the newly isolated P. pastoris AMR2 gene encoding beta 1,2-mannosyltransferase |
| 09/21/2006 | US20060211083 Products and processes for in vitro synthesis of biomolecules |
| 09/21/2006 | US20060211062 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211056 Leishmania antigens suitable for a diagnostic kit of Leishmania |
| 09/21/2006 | US20060211050 Methods of using 18903 to treat pain and pain-related disorders |
| 09/21/2006 | US20060211046 Bacterial ligand-binding sensor |
| 09/21/2006 | US20060211043 Ability to bind to an insect molting hormone such as ecdysteroid; used as insect growth inhibitor is effective for the development of a disinfestant |
| 09/21/2006 | US20060211041 Protein binding to akt2 |
| 09/21/2006 | US20060211038 Methods for detecting vasculopathies and tumors |
| 09/21/2006 | US20060211037 Novel mouse CXC chemokine receptor |
| 09/21/2006 | US20060211033 Novel gene |
| 09/21/2006 | US20060211031 Novel proteins and nucleic acids encoding same |
| 09/21/2006 | US20060211015 detecting a difference between the levels of an expression product of a cancer associated (CA) gene in a cell in the presence and absence of an anticancer drug candidate; for carcinomas, especially lymphoma carcinomas |
| 09/21/2006 | US20060210991 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/21/2006 | US20060210982 Cleavable assigned molecules and screening method using the same |
| 09/21/2006 | US20060210974 Compositions and methods for preventing, treating and diagnosing diabetes |
| 09/21/2006 | US20060210973 Inhibitors of proteins from the rho-gef family |
| 09/21/2006 | US20060210972 Annotation of genome sequences |
| 09/21/2006 | US20060210647 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 09/21/2006 | US20060210601 Stretchable collagen material and manufacturing method and use thereof |
| 09/21/2006 | US20060210589 With botulinum toxin |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | US20060210586 Recombination bcg vaccine |
| 09/21/2006 | US20060210583 Nucleic acids encoding Sarcocystis neurona antigen and uses thereof |
| 09/21/2006 | US20060210582 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210581 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210580 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210579 Nucleic acids and proteins from streptococcus groups A & B |
| 09/21/2006 | US20060210578 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses therof |
| 09/21/2006 | US20060210577 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents |
| 09/21/2006 | US20060210576 Method for treating or preventing metastasis of colorectal cancers |
| 09/21/2006 | US20060210575 Cytotoxic protein and utilization thereof |
| 09/21/2006 | US20060210573 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines; monoclonal, polyclonal, recombinant, synthetic intact antibody and Fv, F(ab'), F(ab')2 and single chain antibody fragments; polynucleotides |
| 09/21/2006 | US20060210560 TNF receptor action modulaton |
| 09/21/2006 | US20060210559 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/21/2006 | US20060210558 Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| 09/21/2006 | US20060210556 Novel composition and methods for the treatment of immune disorders |
| 09/21/2006 | US20060210554 Detection of cholesterol ozonation products |
| 09/21/2006 | US20060210534 Pegylated interleukin-10 |
| 09/21/2006 | US20060210531 Agent eleveting dendritic cell precursor level in blood |
| 09/21/2006 | US20060210493 Peptide that binds to integrins |
| 09/21/2006 | US20060210474 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to a cloned deposit |
| 09/21/2006 | US20060210452 Very large scale immobilized polymer synthesis |
| 09/21/2006 | DE102005011579A1 Affinity marker for molecules has a hemagglutinin epitope (HA) domain with HA tag(s) and a streptavidin (Strep) domain with Strep tag(s) |
| 09/21/2006 | DE102005007480A1 New hydrophobin polypeptide not connected in normal manner with an external hydrophobin useful for coating of a glass surfaces |
| 09/21/2006 | CA2742202A1 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 09/21/2006 | CA2601797A1 Mannose immunogens for hiv-1 |
| 09/21/2006 | CA2601784A1 Acylated glp-1 compounds |
| 09/21/2006 | CA2601677A1 Gene disruptions, compositions and methods relating thereto |
| 09/21/2006 | CA2601668A1 Novel soluble epcr protein of non-proteolytic origin and use thereof |
| 09/21/2006 | CA2601577A1 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 09/21/2006 | CA2601525A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 09/21/2006 | CA2601255A1 Hslim modulates immune responses |
| 09/21/2006 | CA2601243A1 Methods and composition related to in vivo imaging of gene expression |
| 09/21/2006 | CA2601227A1 Mecano growth factor peptides and their use |
| 09/21/2006 | CA2600690A1 Recombinant e-selectin made in insect cells |
| 09/21/2006 | CA2600565A1 Molybdenum transporter and gene thereof |
| 09/21/2006 | CA2600540A1 A novel component of the wg/wnt signaling pathway |
| 09/21/2006 | CA2600505A1 Anti-mesothelin antibodies |
| 09/21/2006 | CA2600026A1 Recombinant expression of defensins in filamentous fungi |
| 09/21/2006 | CA2598230A1 Method and device for detecting feline immunodeficiency virus |
| 09/21/2006 | CA2597325A1 Methods and compositions for modulating vascular integrity |
| 09/21/2006 | CA2596926A1 Extended glp-1 compounds |
| 09/21/2006 | CA2578908A1 Expression vectors for enhanced transient gene expression and mammalian cells expressing them |
| 09/20/2006 | EP1702986A1 BASB013 DNA and proteins from Neisseria meningitidis |
| 09/20/2006 | EP1702985A2 Preferred segments of neural thread protein and methods of using the same |
| 09/20/2006 | EP1702984A2 A method for detecting prostate cancer |
| 09/20/2006 | EP1702980A1 Corynebacterium glutamicum gene encoding Hpr of phosphoenolpyruvate:sugar phosphotransferase system |
| 09/20/2006 | EP1702929A2 Therapeutic use of the smr1 protein and active derivatives thereof |
| 09/20/2006 | EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2006 | EP1702927A1 Attenuated microorganisms for the treatment of infection |
| 09/20/2006 | EP1702914A1 Radio-opaque polymeric biomaterials |
| 09/20/2006 | EP1702625A1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 09/20/2006 | EP1702624A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 09/20/2006 | EP1702518A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 09/20/2006 | EP1702074A2 Prevention of incorporation of non-standard amino acids into protein |
| 09/20/2006 | EP1702069A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 09/20/2006 | EP1702068A1 Latent phase viral interleukin-10-(vii-10) and uses thereof |